ARG1 and diabetes mellitus: In contrast with the proinflammatory response, kidney gene expression of the anti-inflammatory marker Arginase-1 was unaffected by diabetes, but was increased 20-fold at day 10 after IRI, which then declined to 3-fold at day 28 after IRI (Figure 6D).